Catalyst Pharmaceuticals Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$149,390	$152,613	$148,392	$146,563
Gross Profit	125,212	126,539	123,081	116,605
EBITDA	83,082	71,383	80,451	78,753
EBIT	73,232	61,846	71,035	69,293
Net Income	63,734	52,698	52,783	52,108
Net Change In Cash	149,390	152,613	148,392	146,563
Free Cash Flow	59,560	44,859	32,438	71,272
Cash	755,859	709,171	689,892	652,800
Basic Shares	126,903	127,257	127,090	127,543

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$588,989	$491,734	$398,204	$214,203
Gross Profit	501,736	422,889	346,237	179,810
EBITDA	295,651	232,898	119,693	103,077
EBIT	257,778	195,124	86,812	101,838
Net Income	214,326	163,889	71,410	83,079
Net Change In Cash	588,989	491,734	398,204	214,203
Cost of Revenue				126,950
Free Cash Flow	208,612	239,252	61,856	116,018
Cash	709,171	517,553	137,636	298,395
Basic Shares	127,257	124,944	113,753	111,375